Department of Internal Medicine, Nephrology and Hypertensiology CBB

Projects

• Aldosterone and angiotensin II-induced end-organ damage
• Bucher Symposium - Science meets Clinic
• Caveolinopathies, lipid metabolismus and insulin resistance (KFO 192/2)
• Changes in acid-base balance and its effect on metabolism (ESA-AO-06-BR)
• Clinical research group 192 "Regulation and dysregulation of skeletal muscle growth", Core project
• Clinical trials on obesity and cardiovascular end organ damage
• Clinical Trials on Obesity and Hypertension
• Contribution of atrial natriuretic peptide in human metabolism
• Die Rolle von TCF/Lef-Transkriptionsfaktoren in differenzierenden und regenerierenden Nierenepithelien
• Effect of green tea extract TEAVIGO® on fat oxidation
• Effect of HMG-CoA reductase inhibition on ANCA-mediated neutrophil activation
• GRK 1631: International Research Training Group for Myology - MyoGrad
• Heritability of atopic dermatits
• Insulin signaling and metabolism in facioscapulohumeral muscular dystrophy
• Molecular mechanisms in Rats with Angiotensin II-induced end-organ damage Angiotensin II and transgenic rats
• Paradigm for the prevention and treatment of ischemic acute kidney injury (AKI)
• Preclinical testing of renin inhibitors in rats with Ang II-induced end-organ damage
• Presentation of the ANCA-antigen proteinase 3 on neutrophilic granulocytes
• Role of Angiotensin II in diffferentiation and metabolic function of human adipose tissue
• Skeletal muscle growth regulation and dysregulation
• Soluble epoxide hydrolase and the development of hypertension
• Studies to the insulin-like effects after drinking tap water
• The role of -catenin/TCF/Lef-dependent transcription in kidney epithelia during differentation and regeneration
• Treatment of Angiotensin II and end-organ damage
• Type 2 familial partial lipodystrophy
• 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis

If the list does not contain any entry, the request was executed without results.